Master's degree job demand analysis at 首药控股 (More)

?
Growth rate
2026 vs 2025
  • 2025: Down 7%
  • 2024: Up 56%
  • 2023: Down 47%
  • 2022: Up 89%
首药控股 master's hiring over the years:
* Hiring volume was generally low in 2020-2022 due to the pandemic

PhD job demand analysis at 首药控股 (More)

?
Growth rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Up 17%
  • 2023: Down 40%
  • 2022: Up 100%
首药控股 PhD hiring over the years: 2026: 2 more positions than 2025
* Hiring volume was generally low in 2020-2022 due to the pandemic

首药控股 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

People who follow 首药控股 also follow

首药控股 Competitors (Similar Companies)

制药/药业 医药 医药工业 生产
“Continuously innovating to bring patients medicines that significantly”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Dedicated to model animals for 24 years”
“临床和临床前大分子生物分析一站式服务”
制药/药业 抗肿瘤药 肿瘤检测 神经系统疾病药物
“One-stop full-process outsourcing services for drug and medical device”
“Serving human pharmaceutical and health undertakings”
“High-quality life science reagents”
“Pursuing health for all”
医药 药物研发 大健康 药材种植
流程自动化 软件 翻译 特殊教育
生物科技/生物工程 干细胞 再生医学 细胞治疗
“Rapid test product R&D and manufacturer”
合成生物学 脑科学 人工智能 科研机构